Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)
Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL) |
| [26-October-2026] |
Globe Life disclosed roughly $7 million in excess prior-period Medicare Supplement claims linked to a federal CMS processing delay, and GL shares fell over 8%. The investigation concerns what investors were told about the Company's exposure to CMS claims processing. NEW YORK, Oct. 26, 2026 /PRNewswire/ -- Approximately $7 million in excess Medicare Supplement claims from prior periods, paid after a processing delay at the Centers for Medicare & Medicaid Services (CMS), appeared in Globe Life Inc. (NYSE: GL) third-quarter results, and GL shares fell over 8% on October 23, 2026. If you bought Globe Life stock and are now looking at losses, this alert is about your investment. Shareholders who lost money are encouraged to submit your GL loss details now . You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com or by telephone at (888) SueWallSt.
The claims landed in United American, the Globe Life division that writes Medicare Supplement coverage. For the quarter ended September 30, 2026, United American reported a health underwriting margin of negative $6 million on $219 million in health premiums. The Company said the excess claims related to prior periods and were paid because of the CMS processing delay. United American's health business expanded rapidly during the same quarter. Health premiums rose 29% year over year, and health sales climbed 95% to $48 million. Globe Life reported the CMS-related claims with its third-quarter results on October 22, 2026. SueWallSt notifies investors of a pending investigation into potential securities law violations, including whether Globe Life may not have adequately disclosed its exposure to CMS claims-processing changes before that date. Globe Life investors who suffered losses are encouraged to request a free review of your GL losses or call (888) SueWallSt. WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Frequently Asked Questions About the GL Investigation Q: How much did GL stock drop? A: Shares fell over 8% on October 23, 2026. The decline followed Globe Life's third-quarter report, which disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a CMS processing delay. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation. Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Globe Life Inc. made materially false or misleading statements regarding its Medicare Supplement claims experience and its exposure to CMS claims-processing changes. When the Company disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a CMS processing delay, the stock price declined sharply. Q: What do GL investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation. Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices. Q: What if I already sold my GL shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought GL and sold at a loss may still participate in the investigation. Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval. Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either. CONTACT: Levi & Korsinsky, LLP Attorney Advertising. Prior results do not guarantee similar outcomes.
SOURCE SueWallSt.com | ||
Company Codes: NYSE:GL |
View original content to download multimedia:
